Table 5.
Univariable Cox regression analysis of survival
| PFS | OS | |||
|---|---|---|---|---|
| HR | p Value | HR | p Value | |
| Age | 0.0065 | 0.0162 | ||
| Tumor size before therapy | ||||
| cT1 vs. cT2 | 7.621 (1.024–56.707) | 0.0473 | n.s. | |
| Nodal status after therapy | ||||
| yNo vs. yN2, yN3 | 3.377 (1.283–8.890) | 0.0137 | 4.104 (1.201–14.027) | 0.0243 |
| Response to NACT | ||||
| Partial response vs. no response | 3.107 (1.157–8.344) | 0.0245 | n.a. | |
| Complete response vs. no response | 16.974 (1.971–145.174) | 0.0099 | n.s. | |
HR hazard ratio, NACT neoadjuvant chemotherapy, OS overall survival, PFS progression-free survival; n.a. not applicable, n.s. not significant.